Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recently, MM was redefined to include biomarkers predicting a high risk of progression from SMM, thus necessitating a redefinition of SMM and its risk stratification. We assembled a large cohort of SMM patients meeting the revised IMWG criteria to develop a new...Continue Reading

This Policy Review presents the International Myeloma Working Group’s clinical practice recommendations for the treatment of relapsed and  refractory  multiple  myeloma.  Based  on  the  results  of  phase  2  and  phase  3  trials,  these  recommendations are proposed for the treatment of patients with relapsed and refractory disease who have received one  previous  line  of  therapy,  and  for  patients ...Continue Reading

This article was originally posted on Cure Donna gives advice to other multiple myeloma patients about what she has learned from living with this disease and her various therapies. Cristina Gasparetto, MD: We talked about your quality of life. Sometimes patients, they listen to us as physicians, but they listen to patients more. What type of...Continue Reading

This article was originally published on NZ Herald.co.nz Do you know why you’re here? I thought I did until I was asked. I’m in a small, windowless brick room at Auckland Hospital. This starter for 10 was delivered by a man who was to become my clinical haematologist. Until that morning I had no idea...Continue Reading

This article was originally published on The Limbic Australian blood cancer patients are being denied access to life-extending drugs and treatments because of long delays and excessive regulation by the Pharmaceutical Benefits Advisory Committee (PBAC), a parliamentary inquiry has been told. Leading haematologist Professor Andrew Spencer said the registry of myeloma cases established some eight...Continue Reading

This article was originally published by Medical News Today Multiple myeloma is a type of blood cancer that affects plasma cells. Doctors use a three-step staging system to classify the severity of multiple myeloma and whether it has spread. A person may experience different types of symptoms in each stage, and survival rates will change...Continue Reading

This article was originally posted by targeted Oncology Case: A 75-Year-Old Man with Multiple Myeloma Initial Presentation A 75-year-old man presents with worsening fatigue on exertion, pallor, and hip painPMH: osteoarthritisPE: tired appearing male, poor hand-grip strength, mild tenderness on palpation of the left hipECOG 2 Clinical workup Hb 9.8 g/dL, corrected calcium 11.9mg/dL, LDH 295U/L,...Continue Reading

This article was originally published on TheLimbic Australian experts have been ‘startled’ to discover that many patients with multiple myeloma do not receive recommended imaging and staging, sparking concerns about missed diagnoses and overtreatment of benign forms of the disease. The findings come from an analysis of real-world data of more than 2400 newly diagnosed...Continue Reading

This article was originally published on Cure While a diagnosis of multiple myeloma can be overwhelming for patients, the disease is very treatable, according to Dr. Andrew Yee. At CURE®’s Educated Patient® Summit on Multiple Myeloma, Yee, an assistant professor of medicine at Massachusetts General Hospital Cancer Center in Boston, discussed the signs and symptoms of...Continue Reading

This article was originally published on Wiley Online Library There are currently limited Australian data on the outcomes of autologous stem cell transplantation (ASCT) in elderly multiple myeloma (MM) patients. We present the largest cohort of elderly MM patients aged ≥65 years undergoing ASCT in Australia and report their outcomes based on our two‐centre experience. Our...Continue Reading